Weil, Gotshal & Manges represented CBC Group as the lead investor in the transaction.CBC Group executed its acquisition of approximately 43% equity in Yaneng Bioscience (Shenzhen)…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
